News
|
Patent license agreement with KRICT
관리자 │ 2023-05-19 HIT 539 |
|---|
|
Aevisbio and KRICT signed the patent licensing agreement in connection with low-molecular compounds having celeblon-binding activity and their applications. |
| Previous Post | Chemical Research Center founded at Institut Pasteur Korea, Pan-gyo, Korea |
|---|---|
| Next Post | The 6th Target Protein Dissolution Summit |
582 Daedeok-daero, Octo Building 601, Yuseong-gu, Daejeon, Republic of KoreaTel+82 70-4172-2900Fax+82 42-862-3781Mailinfo@aevisbio.com
COPYRIGHT(C) 2022 AEVISBIO, INC. ALL RIGHTS RESERVED.